期刊
ULTRASOUND IN OBSTETRICS & GYNECOLOGY
卷 45, 期 1, 页码 95-100出版社
WILEY-BLACKWELL
DOI: 10.1002/uog.14726
关键词
array comparative genomic hybridization; chromosomal microarray; genomic imbalance; nuchal translucency; prenatal diagnosis
ObjectiveTo assess the clinical value of using high-resolution chromosomal microarray (CMA) for the examination of genomic imbalances in prenatal uncultured chorionic villus samples from fetuses with increased nuchal translucency (NT) and a normal quantitative fluorescent polymerase chain reaction (QF-PCR) result, in a clinical setting in which more than 95% of pregnant women receive first-trimester combined screening. MethodsFrom January 2013 to July 2014, we included 132 chorionic villus samples from consecutive ongoing pregnancies, with fetal NT 3.5mm at 11-13 weeks' gestation, from obstetric units (publicly funded healthcare) in Central and North Denmark Regions. DNA was extracted directly from the samples and examined with QF-PCR (n=132) and 180kb oligonucleotide array-based comparative genomic hybridization (n=94). ResultsIn 38 cases, aneuploidies for chromosomes 18, 21 or X, or triploidy, were detected by QF-PCR. Among the 94 cases with a normal QF-PCR result, we detected pathogenic copy number variants (CNVs) by CMA in 12 fetuses (12.8% (95% CI, 7.5-21.0%)). In an additional three (3.2%) cases, CNVs with uncertain clinical significance were detected. ConclusionCMA is a valuable diagnostic technique in pregnancies with isolated fetal NT 3.5mm. Copyright (c) 2014 ISUOG. Published by John Wiley & Sons Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据